Navigation Links
Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
Date:9/4/2007

The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease. The ADVANCE (Action in Diabetes and Vascular Disease) Study was led by researchers at The George Institute for International Health in Sydney and the results have been presented at the European Congress of Cardiology in Vienna.

One of the study leaders, Professor Stephen MacMahon, Principal Director of The George Institute, said "These results represent an important step forward in the care of people with type 2 diabetes worldwide. This treatment reduced the likelihood of dying from the complications of diabetes by almost one-fifth, and could potentially save several millions of lives over the next decade if the treatment was widely implemented.

More than 600,000 Australians and more than 250 million people worldwide have type 2 diabetes, and most will eventually die or be disabled by the complications. The most common cause of death is heart disease, but kidney disease also affects a large proportion. In 2006, the United Nations called for increased international action to combat the global epidemic of diabetes.

More than 11,000 patients with type 2 diabetes in 20 countries world wide participated in the 4.3 year project. Half received daily treatment with a single tablet containing a fixed combination of two blood pressure lowering drugs (perindopril plus indapamide) and half received matching inactive placebo.

Importantly, the ADVANCE results showed that patients with type 2 diabetes benefited from this blood pressure lowering treatment irrespective of whether or not their blood pressure was elevated to begin with, said study investigator, Dr Bruce Neal, of The George Institute,

The participants in ADVANCE were already receiving most of the usual treatments provided to patients with diabetes, including other drugs to
'/>"/>

Contact: Janet Hall
janethall@bigpond.com
61-411-187-808
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. John Mendelsohn M.D, chosen for an International Award
11. Thailand To Procure Botulism Antitoxin Internationally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...inisters meetings to consider the rising health em...de over the past two days have helped// to promote...e regional meeting saw the attempts for developmen...t Asian regional cooperation during the ASEAN meet...
...t BUPA issued a warning to football fans, ahead of... risk of heart attacks increased by a quarter// d...the first knockout match and could end with penalt...le's emotions run high stress levels can shoot up ...
...ld help reduce muscle damage pain and also be used...Connolly of the University of Vermont and colleagu...e efficacy of a fresh, highly concentrated, specia...in a random study on 14 male college students. Th...
...ade tertiary healthcare infrastructure and provide...grade 13 institutions in the country// at a cost o...decision was taken at a meeting of the Cabinet Com...Prime Minister Manmohan Singh, with an eye on unde...
Other Medicine News:Health News:Regional Cooperation Promoted in Southeast Asia 2
(Date:10/7/2008).../- Prometheus Laboratories Inc., a,sp...ndings from its,development of PROMETHEUS(R) IBS D...able bowel syndrome (IBS). The findings suggest me...ar biomarkers in blood samples,between IBS and non...ers,combined with a proprietary algorithm, led to...
(Date:10/7/2008)...ficacy of new device for detecting polyps that can...y, ORLANDO, Fla., Oct. 7 /- At the A...fic Meeting in Orlando (ACG 2008), renowned,gastro...from a,multi-institutional clinical study that eva...(R), a new device that is designed to improve the ...
(Date:10/7/2008)...rial Presented at the Osteoarthritis Research Soci...NY, N.J., Oct. 7 /- Ferring Pharmaceu...EXX Trial of Osteoarthritis of the,Knee, showing t...pure,non-avian high molecular weight form of intra... intra-articular saline (IA-saline) for the relief...
(Date:10/7/2008)...ide Acetate Prevented Immunologic Changes Induced ...Disease, Additional Data Indicates Potential in Tr... Oct. 7 /- Alba Therapeutics Corporat...is week at the American,College of Gastroenterolog...study CLIN 1001-004, the first Phase IIa trial con...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Dental Services Expand to Serve More Than 280 000 Michigan Children 21751 1Dental Services Expand to Serve More Than 280 000 Michigan Children 21751 2BLIS to Offer Coverage Through A Rated Insurance Carrier 21749 1BLIS to Offer Coverage Through A Rated Insurance Carrier 21749 2BLIS to Offer Coverage Through A Rated Insurance Carrier 21749 3Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference 5973 1Genaera Corporation to Present at BIO Business Forum 5971 1Genaera Corporation to Present at BIO Business Forum 5971 2Genaera Corporation to Present at BIO Business Forum 5971 3
... 2007 /PRNewswire-FirstCall/ -,MIGENIX Inc. , a cl...eases will make a presentation of results from a r...dy (see April 11, 2007,press release) in a non-res...k (DDW) 2007 being held in Washington, DC May 19-2...l Hepatitis,Investigative Unit (VHIU) at the Healt...
...dash; Intercell AG (VSE,“ICLL”) has b...Co., Inc. on the results of a Phase I study involv...paring safety and,immunogenicity of different dose...phylococcus aureus vaccine is based on a conserved...ntigen Identification,Program (AIP®) and was l...
Other Medicine Technology:Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3
... your own cath lab? Worried about the high costs,...adaches of managing the ongoing business operation... service leaving you free to care for your patient...venient diagnostic facility for you and your patie...
...s exactly the same as the model SP-8800 with one b...achy mode. This mode has its own fixation targets .... It allows you to select an area on the cornea to...are to calculate averages of multiple readings in ...
...rSuite holmium laser combines excellent cutting, a...rtually bloodless procedures. It is also extremely... stones of all compositions, making it an ideal mu...is transmitted through flexible fibers, it is espe...
...rSuite holmium laser combines excellent cutting, a...rtually bloodless procedures. It is also extremely... stones of all compositions, making it an ideal mu...is transmitted through flexible fibers, it is espe...
Medicine Products: